Skip to main content
SpringerLink
Log in

Screening for Lung Cancer

  • Chapter
  • First Online:
Book cover Lung Cancer Imaging

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 2633 Accesses

Abstract

With the results of the National Lung Screening Trial (NLST) showing a reduction in lung cancer mortality of 20 % when comparing chest CT to chest radiography, a new dawn has broken in the fight against lung cancer. Until this news, there was no proven method for early detection of lung cancer, and the primary tool was the difficult proposition of smoking cessation. While smoking cessation reduces the risk of developing lung cancer, up to 50 % of newly diagnosed lung cancers occur in former smokers. In addition, once diagnosed, the burden of lung cancer on the healthcare system is tremendous with an estimated cost of treating lung cancer in the United States in 2004 of $9.6 billion dollars. All of this points to a need for effective early detection and treatment that can save both lives and costs. While the NLST confirms the scientific basis of screening, there are certainly questions about feasibility and cost that still dominate the policy discussion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aberle DR, Berg CD, Black WC, et al. The national lung screening trial: overview and study design. Radiology. 2011;258:243–53.

    Article  PubMed  Google Scholar 

  2. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer. 1996;78:1004–10.

    Article  CAS  PubMed  Google Scholar 

  3. Cancer Trends Progress Report—2005 Update. In: National Cancer Institute, NIH, DHHS, Bethesda, MD, December 2005.

    Google Scholar 

  4. Patz Jr E, Goodman P, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343:1627–33.

    Article  PubMed  Google Scholar 

  5. Black W, Haggstrom D, Welch H. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94:167–73.

    Article  PubMed  Google Scholar 

  6. Boucot KR, Weiss W. Is curable lung cancer detected by semiannual screening? JAMA. 1973;224:1361–5.

    Article  CAS  PubMed  Google Scholar 

  7. Brett GZ. Earlier diagnosis and survival in lung cancer. Br Med J. 1969;4:260–2.

    Article  CAS  PubMed  Google Scholar 

  8. Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2001;3, CD001991.

    PubMed  Google Scholar 

  9. Sobue T, Suzuki T, Naruke T. Efficacy of lung cancer screening; comparison of results from a case–control study and a survival analysis. The Japanese Lung Cancer Screening Research Group. Jpn J Cancer Res. 1992;83:424–30.

    Article  CAS  PubMed  Google Scholar 

  10. Tsukada H, Kurita Y, Yokoyama A, et al. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case–control study. Br J Cancer. 2001;85:1326–31.

    Article  CAS  PubMed  Google Scholar 

  11. Sagawa M, Tsubono Y, Saito Y, et al. A case–control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer. 2001;92:588–94.

    Article  CAS  PubMed  Google Scholar 

  12. Nishii K, Ueoka H, Kiura K, et al. A case–control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer. 2001;34:325–32.

    Article  CAS  PubMed  Google Scholar 

  13. Nakayama T, Baba T, Suzuki T, Sagawa M, Kaneko M. An evaluation of chest X-ray screening for lung cancer in Gunma Prefecture, Japan: a population-based case–control study. Eur J Cancer. 2002;38: 1380–7.

    Article  CAS  PubMed  Google Scholar 

  14. Sagawa M, Nakayama T, Tsukada H, et al. The efficacy of lung cancer screening conducted in 1990s: four case–control studies in Japan. Lung Cancer. 2003;41:29–36.

    Article  PubMed  Google Scholar 

  15. Dominioni L, Imperatori A, Rovera F, Ochetti A, Paolucci M, Dionigi G. Lung cancer screening in cigarette smokers in the province of Varese, Italy. Cancer. 2000;89:2345–8.

    Article  CAS  PubMed  Google Scholar 

  16. Salomaa ER. Does the early detection of lung carcinoma improve prognosis? The Turku study. Cancer. 2000;89:2387–91.

    Article  CAS  PubMed  Google Scholar 

  17. Wilde J. A 10 year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. Eur Respir J. 1989;2:656–62.

    CAS  PubMed  Google Scholar 

  18. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer. 1986;57:2427–37.

    Article  CAS  PubMed  Google Scholar 

  19. Kubik A, Parkin D, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial of population of high-risk males in Czechoslovakia. Int J Cancer. 1990;45: 26–33.

    Article  CAS  PubMed  Google Scholar 

  20. Kubik AK, Parkin DM, Zatloukal P. Czech study on lung cancer screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89:2363–8.

    Article  CAS  PubMed  Google Scholar 

  21. Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: introduction. Am Rev Respir Dis. 1984;130:545–9.

    CAS  PubMed  Google Scholar 

  22. Frost JK, Ball Jr WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130:549–54.

    CAS  PubMed  Google Scholar 

  23. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis. 1984;130:555–60.

    CAS  PubMed  Google Scholar 

  24. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984;86:44–53.

    Article  CAS  PubMed  Google Scholar 

  25. Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer. 2000;89:2356–62.

    Article  CAS  PubMed  Google Scholar 

  26. Berlin NI. Overview of the NCI cooperative early lung cancer detection program. Cancer. 2000;89: 2349–51.

    Article  CAS  PubMed  Google Scholar 

  27. Fontana RS, Sanderson DR, Woolner LB, et al. Mayo lung cancer project: status report. Clin Notes Respir Dis. 1976;15:13–4.

    CAS  PubMed  Google Scholar 

  28. Fontana R, Sanderson D, Taylor W, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Stu. Am Rev Respir Dis. 1984;130:561–5.

    CAS  PubMed  Google Scholar 

  29. Fontana RS. The Mayo Lung Project: a perspective. Cancer. 2000;89:2352–5.

    Article  CAS  PubMed  Google Scholar 

  30. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer. 1991;67:1155–64.

    Article  CAS  PubMed  Google Scholar 

  31. Marcus P, Bergstralh E, Fagerstrom R, et al. Lung cancer mortality in Mayo Lung Project: impact of extended follow up. J Natl Cancer Inst. 2000;92: 1308–16.

    Article  CAS  PubMed  Google Scholar 

  32. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal, and ovarian (PLCO) randomized trial. JAMA. 2011;306:1865–73.

    Article  CAS  PubMed  Google Scholar 

  33. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology. 2004;231:440–5.

    Article  PubMed  Google Scholar 

  34. Mascalchi M, Belli G, Zappa M, et al. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJR Am J Roentgenol. 2006;187:421–9.

    Article  PubMed  Google Scholar 

  35. Goodney PP, Lucas FL, Stukel TA, Birkmeyer JD. Surgeon specialty and operative mortality with lung resection. Ann Surg. 2005;241:179–84.

    PubMed  Google Scholar 

  36. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051–6; discussion 6.

    Google Scholar 

  37. Crestanello JA, Allen MS, Jett JR, et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg. 2004;128:254–9.

    Article  PubMed  Google Scholar 

  38. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20:911–20.

    Article  PubMed  Google Scholar 

  39. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest. 2002;122:15–20.

    Article  PubMed  Google Scholar 

  40. Sone S, Li F, Yang ZG, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer. 2001;84:25–32.

    Article  CAS  PubMed  Google Scholar 

  41. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351:1242–5.

    Article  CAS  PubMed  Google Scholar 

  42. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–71.

    Article  PubMed  Google Scholar 

  43. Henschke CI, Yankelevitz DF, Miettinen OS. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med. 2006;166:321–5.

    Article  PubMed  Google Scholar 

  44. Berg CD, Aberle DR. CT screening for lung cancer. N Engl J Med 2007;356:743–4; author reply 6–7.

    Google Scholar 

  45. Patz Jr EF, Swensen SJ, Herndon II JE. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations. J Clin Oncol. 2004;22:2202–6.

    Article  PubMed  Google Scholar 

  46. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol. 2009;4:608–14.

    Article  PubMed  Google Scholar 

  47. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67:296–301.

    Article  PubMed  Google Scholar 

  48. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180:445–53.

    Article  PubMed  Google Scholar 

  49. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120:868–74.

    Article  PubMed  Google Scholar 

  50. Church TR. Chest radiography as the comparison for spiral CT in the national lung screening trial. Acad Radiol. 2003;10:713–5.

    Article  PubMed  Google Scholar 

  51. Aberle DR, Adams AM, Berg CD, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102:1771–9.

    Article  PubMed  Google Scholar 

  52. http://www.cancer.gov/newscenter/pressreleases/NLSTresultsRelease. Accessed 1 May 2011.

  53. Field JK, Smith RA, Aberle DR, et al. International Association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol. 2012;7:10–9.

    Article  PubMed  Google Scholar 

  54. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144:33–8.

    Article  PubMed  Google Scholar 

  55. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening Version 1.2013. 2012.

    Google Scholar 

  56. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health. 1998;19:125–52.

    Article  CAS  PubMed  Google Scholar 

  57. Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest. 2003;124:614–21.

    Article  PubMed  Google Scholar 

  58. Mahadevia PJFL, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA. 2003;289:313–22.

    Article  PubMed  Google Scholar 

  59. Marshall D, Simpson KN, Earle CC, Chu C. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer. 2001;32:227–36.

    Article  CAS  PubMed  Google Scholar 

  60. Marshall D, Simpson KN, Earle CC, Chu CW. Economic decision analysis model of screening for lung cancer. Eur J Cancer. 2001;37:1759–67.

    Article  CAS  PubMed  Google Scholar 

  61. Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71–8.

    Article  CAS  PubMed  Google Scholar 

  62. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007;62:126–30.

    Article  PubMed  Google Scholar 

  63. Mazzone P. The rationale for, and design of, a lung cancer screening program. Cleve Clin J Med. 2012;79:337–45.

    Article  PubMed  Google Scholar 

  64. Rosen MP, Corey J, Siewert B. Establishing a computed tomography screening clinic. J Thorac Imaging. 2012;27:220–3.

    Article  PubMed  Google Scholar 

  65. McMahon PM, Kong CY, Johnson BE, et al. Chapter 9: the MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012;32 Suppl 1:S117–24.

    Article  PubMed  Google Scholar 

  66. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  PubMed  Google Scholar 

  67. McWilliams AM, Mayo JR, Ahn MI, MacDonald SL, Lam SC. Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy. J Thorac Oncol. 2006;1:61–8.

    Article  PubMed  Google Scholar 

  68. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235:259–65.

    Article  PubMed  Google Scholar 

  69. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237:395–400.

    Article  PubMed  Google Scholar 

  70. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology. 2009;250:264–72.

    Article  PubMed  Google Scholar 

  71. Ishikawa H, Koizumi N, Morita T, Tsuchida M, Umezu H, Sasai K. Ultrasmall intrapulmonary lymph node: usual high-resolution computed tomographic findings with histopathologic correlation. J Comput Assist Tomogr. 2007;31:409–13.

    Article  PubMed  Google Scholar 

  72. Shaham D, Vazquez M, Bogot NR, Henschke CI, Yankelevitz DF. CT features of intrapulmonary lymph nodes confirmed by cytology. Clin Imaging. 2010;34: 185–90.

    Article  PubMed  Google Scholar 

  73. Revel MP, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology. 2004;231:453–8.

    Article  PubMed  Google Scholar 

  74. Gietema HA, Wang Y, Xu D, et al. Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology. 2006;241:251–7.

    Article  PubMed  Google Scholar 

  75. Revel MP, Lefort C, Bissery A, et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology. 2004;231:459–66.

    Article  PubMed  Google Scholar 

  76. Ravenel JG, Leue WM, Nietert PJ, Miller JV, Taylor KK, Silvestri GA. Pulmonary nodule volume: effects of reconstruction parameters on automated measurements–a phantom study. Radiology. 2008;247:400–8.

    PubMed  Google Scholar 

  77. Gietema HA, Schaefer-Prokop CM, Mali WP, Groenewegen G, Prokop M. Pulmonary nodules: interscan variability of semiautomated volume measurements with multisection CT—influence of inspiration level, nodule size, and segmentation performance. Radiology. 2007;245:888–94.

    Article  PubMed  Google Scholar 

  78. Petrou M, Quint LE, Nan B, Baker LH. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology. AJR Am J Roentgenol. 2007;188:306–12.

    Article  PubMed  Google Scholar 

  79. Goo JM, Kim KG, Gierada DS, Castro M, Bae KT. Volumetric measurements of lung nodules with multi-detector row CT: effect of changes in lung volume. Korean J Radiol. 2006;7:243–8.

    Article  PubMed  Google Scholar 

  80. Boll DT, Gilkeson RC, Fleiter TR, Blackham KA, Duerk JL, Lewin JS. Volumetric assessment of pulmonary nodules with ECG-gated MDCT. AJR Am J Roentgenol. 2004;183:1217–23.

    Article  PubMed  Google Scholar 

  81. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221–9.

    Article  PubMed  Google Scholar 

  82. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002;178:1053–7.

    Article  PubMed  Google Scholar 

  83. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.

    Article  PubMed  Google Scholar 

  84. Godoy MC, Naidich DP. Overview and strategic management of subsolid pulmonary nodules. J Thorac Imaging. 2012;27:240–8.

    Article  PubMed  Google Scholar 

  85. Lee SM, Park CM, Goo JM, et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology. 2010;255:242–51.

    Article  PubMed  Google Scholar 

  86. Franks TJ, Galvin JR, Jett JR, Naidich DP, Boiselle PM. Expert opinion: role of percutaneous biopsy of part-solid nodules in the IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma. J Thorac Imaging. 2011;26:189.

    Article  PubMed  Google Scholar 

  87. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73:1252–9.

    CAS  PubMed  Google Scholar 

  88. Naidich DP, Bankier AA, Macmahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013;266(1): 304–17.

    Article  PubMed  Google Scholar 

  89. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009;136:1586–95.

    Article  PubMed  Google Scholar 

  90. de Hoop B, Gietema H, van de Vorst S, Murphy K, van Klaveren RJ, Prokop M. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology. 2010;255:199–206.

    Article  PubMed  Google Scholar 

  91. Park CM, Goo JM, Lee HJ, Kim KG, Kang MJ, Shin YH. Persistent pure ground-glass nodules in the lung: interscan variability of semiautomated volume and attenuation measurements. AJR Am J Roentgenol. 2010;195:W408–14.

    Article  PubMed  Google Scholar 

  92. Kim TJ, Park CM, Goo JM, Lee KW. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? AJR Am J Roentgenol. 2012;198:83–8.

    Article  PubMed  Google Scholar 

  93. Okada M, Nakayama H, Okumura S, et al. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141:1384–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, 96 Jonathan Lucas St Room 211, 250322, Charleston, SC, 29425, USA

    James G. Ravenel M.D.

Authors
  1. James G. Ravenel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James G. Ravenel M.D. .

Editor information

Editors and Affiliations

  1. Medical University of South Carolina, Department of Radiology, Ashley Ave. 169, Charleston, 29425, South Carolina, USA

    James G. Ravenel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ravenel, J.G. (2013). Screening for Lung Cancer. In: Ravenel, J. (eds) Lung Cancer Imaging. Contemporary Medical Imaging. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-620-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-620-7_3

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-60761-619-1

  • Online ISBN: 978-1-60761-620-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation